GLP‐1 receptor agonists in hip, knee and shoulder arthroplasty: Implications for obesity, osteoarthritis, metabolic optimisation and complications
Knee Surgery, Sports Traumatology, Arthroscopy · 01.08.2026
DOI: 10.1002/ksa.70557 ↗Kurz gefasst
Editorial in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, online erschienen am 01.08.2026. Verfasst von George M Avram und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, Research Group Michael T. Hirschmann, Regenerative Medicine & Biomechanics, University of Basel, Basel, Switzerland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Glucagon‐like peptide‐1 receptor agonists and related incretin‐based therapies are rapidly changing the management of obesity and metabolic disease. Their increasing use also among patients with osteoarthritis has important implications for hip, knee and shoulder arthroplasty. Beyond weight loss, these drugs may influence systemic inflammation, glycemic control, osteoarthritic symptoms, perioperative complications and surgical candidacy. Recent retrospective studies suggest that preoperative GLP‐1 receptor agonist use may be associated with lower risks of periprosthetic joint infection, hospital readmission and other adverse outcomes after total joint arthroplasty. Beyond the perioperative setting, GLP‐1 receptor agonists have also been associated with reductions in blood pressure and significant improvements in cardiovascular risk among patients with chronic kidney disease or preexisting cardiovascular disease. However, the current evidence remains largely observational and is limited by residual confounding, indication bias, heterogeneity in treatment timing, and inconsistent reporting of drug class, dose, and duration. This editorial argues that GLP‐1 receptor agonists should not be viewed simply as weight‐loss agents before arthroplasty, but as part of a broader movement toward metabolic optimisation. Prospective studies are needed before these therapies can be incorporated into standardised arthroplasty optimisation pathways.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Research, Research Group Michael T. Hirschmann, Regenerative Medicine & Biomechanics, University of Basel, Basel, Switzerland.
- Department of Orthopaedics and Traumatology, Central Military Emergency University Hospital, Bucharest, Romania.
- CIBIO - Department of Cellular, Computational and Integrative Biology, University of Trento School of Medicine, Trento, Italy.
- The Breyer Center for Overseas Studies, Stanford University, Florence, Italy.
- Center for Knee and Hip Reconstructive Surgery and Traumatology, Hospital Isola Tiberina, Gemelli Isola, Rome, Italy.
- Department of Personalised Orthopaedics (PersO), Privatklinik Siloah, Muri bei Bern, Switzerland.
ORCID-Profile: George M Avram, M Enes Kayaalp
Zitieren
APA
Avram, G. M., Indelli, P. F., Violante, B., Graichen, H., Lustig, S., Boettner, F., von Eisenhart-Rothe, R., Tandogan, R., Hirschmann, M. T., & Kayaalp, M. E. (2026). GLP‐1 receptor agonists in hip, knee and shoulder arthroplasty: Implications for obesity, osteoarthritis, metabolic optimisation and complications. Knee Surgery, Sports Traumatology, Arthroscopy. https://doi.org/10.1002/ksa.70557
Vancouver
Avram GM, Indelli PF, Violante B, Graichen H, Lustig S, Boettner F, et al. GLP‐1 receptor agonists in hip, knee and shoulder arthroplasty: Implications for obesity, osteoarthritis, metabolic optimisation and complications. Knee Surgery, Sports Traumatology, Arthroscopy. 2026. doi:10.1002/ksa.70557
BibTeX
@article{Avram2026,
author = {Avram, George M and Indelli, Pier Francesco and Violante, Bruno and Graichen, Heiko and Lustig, Sebastien and Boettner, Friedrich and von Eisenhart-Rothe, Rüdiger and Tandogan, Reha and Hirschmann, Michael T and Kayaalp, M Enes},
title = {GLP‐1 receptor agonists in hip, knee and shoulder arthroplasty: Implications for obesity, osteoarthritis, metabolic optimisation and complications},
journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
year = {2026},
doi = {10.1002/ksa.70557}
}
EUVIMED